Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave's Q3 Revenues Grow 24 Percent, Loss Rises

NEW YORK (GenomeWeb News) — Third Wave Technologies today said third-quarter revenues grew 24 percent as R&D spending rose 68 percent and its net loss widened 25 percent. 
Total receipts for the three months ended Sept. 30 increased to $8.2 million from $6.6 million year over year.
Revenue from clinical products rose 25 percent to $6.7 million, while receipts from research products increased 19 percent to $1.4 million.
The firm’s R&D expenses rose to $5.8 million from $3.5 million the previous year.
Third Wave’s net loss for the period swelled to $6.4 million from $5.2 million year over year, due in part to $1.8 million in litigation charges during the quarter.
The firm is locked in an ongoing patent and antitrust dispute with Digene, which recently was acquired by Qiagen.
Third Wave had around $43.6 million in cash, cash equivalents, and short-term investments as of Sept. 30.
The company also reaffirmed its previously announced guidance of 2007 clinical molecular diagnostics revenue of $26 million to $28 million and total revenue of $31 million to $33 million.
"We believe Third Wave is well positioned to create a sustainable competitive advantage through unique HPV products and an automated instrument offering, and through leadership in the rapidly-growing hospital laboratory market,” Third Wave President and CEO Kevin Conroy said in a statement.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.